Hammersmith Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2022

  1. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

    ESMO Open, Vol. 7, Núm. 2

2001

  1. Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: A retrospective registry study from the European group for blood and marrow transplantation (EBMT)

    Bone Marrow Transplantation, Vol. 27, Núm. 5, pp. 511-515

1985

  1. Blast crisis of chronic lymphocytic leukemia with mast cell and basophilic precursors

    American Journal of Clinical Pathology, Vol. 83, Núm. 2, pp. 254-259

  2. Osteolytic lesion as the presenting feature of chronic granulocytic leukaemia

    Clinical & Laboratory Haematology, Vol. 7, Núm. 2, pp. 105-112

1984

  1. Changes in surface antigens of HL-60 cells during differentiation in vitro

    Blut, Vol. 49, Núm. 5, pp. 369-373

  2. Chronic T cell lymphocytosis: a review of 21 cases

    British Journal of Haematology, Vol. 58, Núm. 3, pp. 433-446

  3. Method for the simultaneous labelling of terminal deoxynucleotidyl transferase (TdT) and membrane antigens

    Journal of Clinical Pathology, Vol. 37, Núm. 6, pp. 628-632

1983

  1. 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells

    Leukemia Research, Vol. 7, Núm. 1, pp. 51-55